Gene Panel Market – By Type, By Product, By Technique, By Sample ,By Application , By End User, By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030

Report Code: HCR 32798 Report Format: PDF + Excel

Gene Panel Market Overview

Gene Panel Market size is expected to be valued at $8.6 billion by the end of the year 2030 and the gene panel industry is set to grow at a CAGR of 17.9% during the forecast period from 2024-2030. Gene panel is a targeted approach that allows for the simultaneous sequencing of multiple genes known to be associated with a particular disease, syndrome or phenotype. The rising prevalence of cancer and awareness regarding rare diseases are driving the market. Additionally, the increasing investments and R&D in the field of genetics boosts the market. Moreover, the importance of prenatal screening in high-risk pregnancies is driving the gene panel market.

Technological advancements in Next-Generation Sequencing (NGS) is a pivotal trend in the gene panel market. NGS allows for the simultaneous sequencing of numerous genes or entire genomes with increased speed, accuracy, and cost-effectiveness. This high-throughput technology enables comprehensive genetic analysis, providing detailed information on genetic variants, which is crucial for diagnosing diseases and developing personalized treatments. The rise in direct-to-consumer (DTC) gene panels is a notable trend in the market, enabling individuals to access their genetic information without going through a healthcare provider.

Gene Panel Market – Report Coverage

The report: “Gene Panel Market – Forecast (2024-2030)”, by IndustryARC, covers an in-depth analysis of the following segments of the Gene Panel Industry.

Attribute Segment

By Type

●   Pre designed Panel

●   Customized Panel

By Product

●        Testing Kits

●       Testing Services

By Technique

●       Enrichment

●       Targeted Sequence

By Sample

●       Blood

●       Saliva

●       Amniotic Fluid & CVS

●       Others

By Application

●   Cancer Diagnostics

●   Prenatal Screening

●   Predictive Testing

●   Pharmacogenomics

●   Research

●   Others

By End User

●       Hospitals and Diagnostic Laboratories

●       Research and Academic Institutions

●       Pharmaceutical and Biotechnology Companies

●       Others

By Geography

●       North America (U.S., Canada and Mexico)

●       Europe (Germany, France, UK, Italy, Spain, Belgium, Denmark, Netherlands and Rest of Europe)

●       Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Malaysia, Indonesia and Rest of Asia-Pacific)

●       South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

●   Rest of the World (Middle East and Africa)

COVID-19 / Ukraine Crisis - Impact Analysis: 

  • The COVID-19 pandemic significantly impacted the gene panel market. On one hand, disruptions in healthcare services and supply chains during the pandemic delayed genetic testing procedures affecting the market's growth. Many elective medical procedures including non-urgent genetic tests were postponed. However, the pandemic also accelerated the adoption of telemedicine and home testing kits which spurred interest in genetic testing from remote settings.
  • The Russia-Ukraine war added challenges to the global gene panel market particularly in terms of supply chain disruptions and increased geopolitical tensions. Many suppliers and manufacturers in the life sciences sector experienced delays in the transportation of raw materials and equipment affecting the production and distribution of genetic testing products. Additionally, countries are focused on increasing defense spending which could reduce the budget towards genetic testing

Key Takeaways

Pre-Designed Panels are the Largest Segment

Pre-designed gene panels dominate the market by type, offering a streamlined and efficient approach for genetic testing. These panels are tailored for specific conditions or diseases, allowing healthcare providers to quickly assess a patient’s genetic predisposition without the need for customization. They help identify cancer-related mutations for personalized treatment, diagnose rare genetic conditions, and screen for genetic abnormalities in fetuses. NHS England aims to sequence 500,000 whole genomes by 2023/24 as part of a broader initiative to achieve five million genomic tests. The UK has a high newborn screening uptake of around 97%, indicating strong public engagement in genomic medicine. Additionally, the cost-effectiveness of pre-designed panels compared to custom panels, makes them accessible to a larger patient population further contributing to the largest share in the gene panel market.

Cancer Diagnostics Dominates the Market

Cancer diagnostics represents the largest segment of the gene panel market due to the increasing use of gene panels in oncology for detecting cancer related mutations. The demand for cancer gene panels is further bolstered by increasing cancer screening programs and initiatives aimed at improving patient outcomes through early detection. For instance, The Finnish Government announced that screening for colorectal cancer will be made nationwide from 2022 onwards. Screening will be introduced among men and women aged 60–68 years. Screening will be expanded by age group, and it will cover all 56–74-year-olds by 2031. Gene panels enable healthcare providers to identify multiple mutations simultaneously offering insights into tumor biology and guiding targeted therapies. With the growing use of immunotherapies gene panel testing is essential for determining the most effective treatment options. 

North America Leads the Market

North America dominates the gene panel market due to its advanced healthcare infrastructure, high adoption of genetic testing and high healthcare spending. For instance, the Canadian Institute for Health Information (CIHI) stated that Canada’s healthcare expenditure was roughly 11.5% of its GDP in 2023. The region’s healthcare system is well-equipped with cutting-edge technology which facilitates the widespread use of gene panels for diagnostics. Furthermore, regulatory support for genetic testing, coupled with favorable reimbursement policies encourages both healthcare providers and patients to embrace gene panel testing. For instance, a new law passed in July 2024, Public Act 24-130, in Connecticut will make rapid genetic testing available to families on Medicaid with critically ill newborns. The law requires Medicaid to cover rapid Whole Genome Sequencing (rWGS) for certain critically ill newborns. The testing is used to deliver accurate diagnoses more quickly to inform clinical decision making for patients especially those with rare diseases, suspected genetic disorders and for undiagnosed chronically ill children. 

Rising Prevalence of Cancer Drives the Market

The rising prevalence of cancer globally is a significant driver for the single agent chemotherapy market growth. According to the World Health Organisation, globally over 35 million new cancer cases are predicted in 2050, an increase from the estimated 20 million in 2022. With several new cancer cases diagnosed every year, the demand for early detection continues to grow. As per the WHO, early diagnosis of cancer generally increases the chances for successful treatment. Advances in screening techniques and increased awareness have led to more frequent and earlier cancer diagnoses necessitating the need for oncology gene panels. As a result, several companies are entering this space. For instance, in October 2023, Invitae announced it gained FDA market authorization for its Common Hereditary Cancers Panel. 

Regulatory Issues to Hamper the Market

Regulatory issues presents a significant challenges for the gene panel market. The variability in regulatory requirements and reimbursement policies across different regions can create obstacles for the widespread adoption of gene panels. Different countries have distinct standards for the approval and reimbursement of genetic tests, which can lead to inconsistencies and delays in market entry. This fragmentation complicates the process for manufacturers and providers, potentially hindering the growth of the gene panel market and limiting access to these advanced diagnostic tools. Addressing these regulatory and reimbursement challenges is essential for facilitating broader adoption and integration of gene panels into clinical practice.  According to Integrated DNA Technologies, cell and gene therapies (CGT) offer promising solutions for previously untreatable conditions, but their journey from discovery to market is fraught with regulatory challenges.

Gene Panel Market Key Players:

  1. Illumina, Inc. 
  2. Thermo Fisher Scientific 
  3.  Agilent Technologies, Inc. 
  4.   QIAGEN 
  5.  Integrated DNA Technologies, Inc. 
  6.  Becton, Dickinson and Company (BD)
  7.  F. Hoffmann-La Roche AG 
  8. Invitae Corporation
  9.  Myriad Genetics, Inc.
  10.  Eurofins Scientific

Scope of the Report: 

Report Metric Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

17.9%

Market Size in 2030

$8.6 Billion

Segments Covered

By Type, By Product, By Technique, By Sample, By Application, By End User and By Geography.

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Belgium, Denmark, Netherlands and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Malaysia, Indonesia and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa)

Key Market Players

1.      Illumina, Inc.

2.      Thermo Fisher Scientific

3.      Agilent Technologies, Inc.

4.      QIAGEN

5.      Integrated DNA Technologies, Inc.

6.      Becton, Dickinson and Company (BD)

7.      F. Hoffmann-La Roche AG

8.      Invitae Corporation

9.      Myriad Genetics, Inc.

10.  Eurofins Scientific

For more Lifesciences and Healthcare Market reports, please click here

  1. Gene Panel Market - Market Overview
          1.1 Definitions and Scope
  2. Gene Panel Market - Executive Summary
          2.1 Key trends by Panel Design
          2.2 Key trends by Products or Services
          2.3 Key trends by Application
          2.4 Key trends by Type
          2.5 Key trends by End User 
          2.6 Key trends by Geography
  3. Gene Panel Market – Landscape
          3.1 Comparative analysis
                    3.1.1 Market Share Analysis- Major Companies
                    3.1.2 Product Benchmarking- Major Companies
                    3.1.3 Major 5 Financials Analysis
                    3.1.4 Patent Analysis- Top Companies
                    3.1.5 Pricing Analysis (ASPs will be provided)
  4. Gene Panel Market - Startup companies Scenario Premium 
          4.1 Top startup company Analysis by
                    4.1.1 Investment
                    4.1.2 Revenue
                    4.1.3 Market Shares
                    4.1.4 Market Size and Application Analysis
                    4.1.5 Venture Capital and Funding Scenario
  5. Gene Panel  Market – Industry Market Entry Scenario Premium 
          5.1 Regulatory Framework Overview
          5.2 New Business and Ease of Doing business index
          5.3 Successful venture profiles
          5.4 Customer Analysis – Major companies
  6. Gene Panel Market - Market Forces
          6.1 Market Drivers
          6.2 Market Constraints
          6.3 Porters Five Force Model
                    6.3.1 Bargaining Power of Suppliers
                    6.3.2 Bargaining Powers of Buyers
                    6.3.3 Threat of New Entrants
                    6.3.4 Competitive Rivalry
                    6.3.5 Threat of Substitutes 
  7. Gene Panel Market – Strategic Analysis
          7.1 Value/Supply Chain Analysis
          7.2 Opportunity Analysis
          7.3 Product/Market Life Cycle
          7.4 Distributor Analysis – Major Companies 
  8. Gene Panel Market By - Panel Design (Market Size -$Million/Billion)
          8.1 Pre-Designed Panel
          8.2 Custom Designed Panel
  9. Gene Panel Market By - Product (Market Size -$Million/Billion)
          9.1 Testing Kit
             9.1 Reagents
             9.2 Instruments
          9.2 Testing Services
    10. Gene Panel Market By - Technique (Market Size -$Million/Billion)
               10.1 Enrichment
            10.1.1 Hybridization Capture 
            10.1.2 Molecular Inversion Probes (MIPs)
               10.2 Targeted Sequence
            10.2.1 Amplicon-Based Approach
            10.2.2 PCR-Based Targeted Sequencing
            10.2.3 Molecular Inversion Probes (MIPs)
    11. Gene Panel Market By - Sample (Market Size -$Million/Billion)
               11.1 Blood
               11.2 Saliva
               11.3 Amniotic Fluid & CVS
               11.4 Others
  12. Gene Panel Market By - Application (Market Size -$Million/Billion)
            12.1 Cancer Diagnostics
            12.1.1 Syndrome Specific
            12.1.2 High Penetrance
            12.1.3 High & Moderate Penetrance
            12.1.4 Comprehensive Cancer Risk 
            12.2 Prenatal Screening
            12.3 Predictive Testing
            12.4 Pharmacogenomics
            12.5 Research Applications
            12.6 Others
    13. Gene Panel Market By - End User (Market Size -$Million/Billion)
      13.1 Hospitals and Diagnostic Laboratories
      13.2 Research and Academic Institutions
      13.3 Pharmaceutical and Biotechnology Companies
      13.4 Others
   14. Gene Panel Market By - Geography (Market Size -$Million/Billion)
          14.1 North America
                    14.1.1 U.S
                    14.1.2 Canada
                    14.1.3 Mexico
          14.2 Europe
                    14.2.1 UK
                    14.2.2 Germany
                    14.2.3 France
                    14.2.4 Italy
                    14.2.5 Netherlands
                    14.2.6 Spain
                    14.2.7 Denmark
                    14.2.8 Belgium
                    14.2.9 Rest of Europe
          14.3 Asia-Pacific
                    14.3.1 China
                    14.3.2 Japan
                    14.3.3 India
                    14.3.4 South Korea
                    14.3.5 Indonesia
                    14.3.6 Australia
                    14.3.7 Malaysia
                    14.3.8 New Zealand
                    14.3.9 Rest of APAC
          14.4 South America
                    14.4.1 Brazil
                    14.4.2 Argentina
                    14.4.3 Colombia
                    14.4.4 Chile
                    14.4.5 Rest of South America
          14.5 Rest of the World
                    14.5.1 Middle East
                    14.5.2 Africa
  15. Gene Panel Market – Entropy
          15.1 New Product Launches
          15.2 M&As, Collaborations, JVs and Partnerships
  16. Gene Panel Market – Market Share Analysis 
          16.1 Market Share at Global Level - Major companies
          16.2 Market Share by Key Region - Major companies
          16.3 Market Share by Key Country - Major companies
          16.4 Market Share by Key Application - Major companies
          16.5 Market Share by Key Product Type/Product category - Major companies
  17. Gene Panel Market – Key Company List by Country Premium 
  18. Gene Panel Market Company Analysis
          18.1 Illumina, Inc. 
          18.2 Thermo Fisher Scientific 
          18.3 Agilent Technologies, Inc. 
          18.4 QIAGEN
          18.5 Integrated DNA Technologies, Inc.
          18.6 Becton, Dickinson and Company (BD)
          18.7 F. Hoffmann-La Roche AG
          18.8 Invitae Corporation
          18.9 Myriad Genetics, Inc.
          18.10 Eurofins Scientific
  "Financials to the Private Companies would be provided on best-effort basis."
   
  Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.
   

LIST OF TABLES

1.Global Gene Panel Market, By Product & Service Market 2023-2030 ($M)
1.1 Test Kit Market 2023-2030 ($M) - Global Industry Research
1.2 Testing Service Market 2023-2030 ($M) - Global Industry Research
2.Global Gene Panel Market, By Technique Market 2023-2030 ($M)
2.1 Amplicon-Based Approach Market 2023-2030 ($M) - Global Industry Research
2.2 Hybridization-Based Approach Market 2023-2030 ($M) - Global Industry Research
3.Global Gene Panel Market, By Design Market 2023-2030 ($M)
3.1 Predesigned Gene Panel Market 2023-2030 ($M) - Global Industry Research
3.2 Customized Gene Panel Market 2023-2030 ($M) - Global Industry Research
4.Global Gene Panel Market, By End User Market 2023-2030 ($M)
4.1 Research & Academic Institute Market 2023-2030 ($M) - Global Industry Research
4.2 Hospital & Diagnostic Laboratory Market 2023-2030 ($M) - Global Industry Research
4.3 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Global Industry Research
5.Global Gene Panel Market, By Product & Service Market 2023-2030 (Volume/Units)
5.1 Test Kit Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Testing Service Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Gene Panel Market, By Technique Market 2023-2030 (Volume/Units)
6.1 Amplicon-Based Approach Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Hybridization-Based Approach Market 2023-2030 (Volume/Units) - Global Industry Research
7.Global Gene Panel Market, By Design Market 2023-2030 (Volume/Units)
7.1 Predesigned Gene Panel Market 2023-2030 (Volume/Units) - Global Industry Research
7.2 Customized Gene Panel Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Gene Panel Market, By End User Market 2023-2030 (Volume/Units)
8.1 Research & Academic Institute Market 2023-2030 (Volume/Units) - Global Industry Research
8.2 Hospital & Diagnostic Laboratory Market 2023-2030 (Volume/Units) - Global Industry Research
8.3 Pharmaceutical & Biotechnology Company Market 2023-2030 (Volume/Units) - Global Industry Research
9.North America Gene Panel Market, By Product & Service Market 2023-2030 ($M)
9.1 Test Kit Market 2023-2030 ($M) - Regional Industry Research
9.2 Testing Service Market 2023-2030 ($M) - Regional Industry Research
10.North America Gene Panel Market, By Technique Market 2023-2030 ($M)
10.1 Amplicon-Based Approach Market 2023-2030 ($M) - Regional Industry Research
10.2 Hybridization-Based Approach Market 2023-2030 ($M) - Regional Industry Research
11.North America Gene Panel Market, By Design Market 2023-2030 ($M)
11.1 Predesigned Gene Panel Market 2023-2030 ($M) - Regional Industry Research
11.2 Customized Gene Panel Market 2023-2030 ($M) - Regional Industry Research
12.North America Gene Panel Market, By End User Market 2023-2030 ($M)
12.1 Research & Academic Institute Market 2023-2030 ($M) - Regional Industry Research
12.2 Hospital & Diagnostic Laboratory Market 2023-2030 ($M) - Regional Industry Research
12.3 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
13.South America Gene Panel Market, By Product & Service Market 2023-2030 ($M)
13.1 Test Kit Market 2023-2030 ($M) - Regional Industry Research
13.2 Testing Service Market 2023-2030 ($M) - Regional Industry Research
14.South America Gene Panel Market, By Technique Market 2023-2030 ($M)
14.1 Amplicon-Based Approach Market 2023-2030 ($M) - Regional Industry Research
14.2 Hybridization-Based Approach Market 2023-2030 ($M) - Regional Industry Research
15.South America Gene Panel Market, By Design Market 2023-2030 ($M)
15.1 Predesigned Gene Panel Market 2023-2030 ($M) - Regional Industry Research
15.2 Customized Gene Panel Market 2023-2030 ($M) - Regional Industry Research
16.South America Gene Panel Market, By End User Market 2023-2030 ($M)
16.1 Research & Academic Institute Market 2023-2030 ($M) - Regional Industry Research
16.2 Hospital & Diagnostic Laboratory Market 2023-2030 ($M) - Regional Industry Research
16.3 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
17.Europe Gene Panel Market, By Product & Service Market 2023-2030 ($M)
17.1 Test Kit Market 2023-2030 ($M) - Regional Industry Research
17.2 Testing Service Market 2023-2030 ($M) - Regional Industry Research
18.Europe Gene Panel Market, By Technique Market 2023-2030 ($M)
18.1 Amplicon-Based Approach Market 2023-2030 ($M) - Regional Industry Research
18.2 Hybridization-Based Approach Market 2023-2030 ($M) - Regional Industry Research
19.Europe Gene Panel Market, By Design Market 2023-2030 ($M)
19.1 Predesigned Gene Panel Market 2023-2030 ($M) - Regional Industry Research
19.2 Customized Gene Panel Market 2023-2030 ($M) - Regional Industry Research
20.Europe Gene Panel Market, By End User Market 2023-2030 ($M)
20.1 Research & Academic Institute Market 2023-2030 ($M) - Regional Industry Research
20.2 Hospital & Diagnostic Laboratory Market 2023-2030 ($M) - Regional Industry Research
20.3 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
21.APAC Gene Panel Market, By Product & Service Market 2023-2030 ($M)
21.1 Test Kit Market 2023-2030 ($M) - Regional Industry Research
21.2 Testing Service Market 2023-2030 ($M) - Regional Industry Research
22.APAC Gene Panel Market, By Technique Market 2023-2030 ($M)
22.1 Amplicon-Based Approach Market 2023-2030 ($M) - Regional Industry Research
22.2 Hybridization-Based Approach Market 2023-2030 ($M) - Regional Industry Research
23.APAC Gene Panel Market, By Design Market 2023-2030 ($M)
23.1 Predesigned Gene Panel Market 2023-2030 ($M) - Regional Industry Research
23.2 Customized Gene Panel Market 2023-2030 ($M) - Regional Industry Research
24.APAC Gene Panel Market, By End User Market 2023-2030 ($M)
24.1 Research & Academic Institute Market 2023-2030 ($M) - Regional Industry Research
24.2 Hospital & Diagnostic Laboratory Market 2023-2030 ($M) - Regional Industry Research
24.3 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research
25.MENA Gene Panel Market, By Product & Service Market 2023-2030 ($M)
25.1 Test Kit Market 2023-2030 ($M) - Regional Industry Research
25.2 Testing Service Market 2023-2030 ($M) - Regional Industry Research
26.MENA Gene Panel Market, By Technique Market 2023-2030 ($M)
26.1 Amplicon-Based Approach Market 2023-2030 ($M) - Regional Industry Research
26.2 Hybridization-Based Approach Market 2023-2030 ($M) - Regional Industry Research
27.MENA Gene Panel Market, By Design Market 2023-2030 ($M)
27.1 Predesigned Gene Panel Market 2023-2030 ($M) - Regional Industry Research
27.2 Customized Gene Panel Market 2023-2030 ($M) - Regional Industry Research
28.MENA Gene Panel Market, By End User Market 2023-2030 ($M)
28.1 Research & Academic Institute Market 2023-2030 ($M) - Regional Industry Research
28.2 Hospital & Diagnostic Laboratory Market 2023-2030 ($M) - Regional Industry Research
28.3 Pharmaceutical & Biotechnology Company Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Gene Panel Market Revenue, 2023-2030 ($M)
2.Canada Gene Panel Market Revenue, 2023-2030 ($M)
3.Mexico Gene Panel Market Revenue, 2023-2030 ($M)
4.Brazil Gene Panel Market Revenue, 2023-2030 ($M)
5.Argentina Gene Panel Market Revenue, 2023-2030 ($M)
6.Peru Gene Panel Market Revenue, 2023-2030 ($M)
7.Colombia Gene Panel Market Revenue, 2023-2030 ($M)
8.Chile Gene Panel Market Revenue, 2023-2030 ($M)
9.Rest of South America Gene Panel Market Revenue, 2023-2030 ($M)
10.UK Gene Panel Market Revenue, 2023-2030 ($M)
11.Germany Gene Panel Market Revenue, 2023-2030 ($M)
12.France Gene Panel Market Revenue, 2023-2030 ($M)
13.Italy Gene Panel Market Revenue, 2023-2030 ($M)
14.Spain Gene Panel Market Revenue, 2023-2030 ($M)
15.Rest of Europe Gene Panel Market Revenue, 2023-2030 ($M)
16.China Gene Panel Market Revenue, 2023-2030 ($M)
17.India Gene Panel Market Revenue, 2023-2030 ($M)
18.Japan Gene Panel Market Revenue, 2023-2030 ($M)
19.South Korea Gene Panel Market Revenue, 2023-2030 ($M)
20.South Africa Gene Panel Market Revenue, 2023-2030 ($M)
21.North America Gene Panel By Application
22.South America Gene Panel By Application
23.Europe Gene Panel By Application
24.APAC Gene Panel By Application
25.MENA Gene Panel By Application
26.Illumina, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Thermo Fisher Scientific Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Agilent, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Qiagen, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Eurofins Scientific Se, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Bgi, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Integrated Dna Technology, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Genewiz, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Novogene Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Personalis, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Gatc Biotech Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.Archerdx, Sales /Revenue, 2015-2018 ($Mn/$Bn)

The Gene Panel Market is projected to grow at 17.9% CAGR during the forecast period 2024-2030.

The Gene Panel Market size is estimated to be $2.6 billion in 2023 and is projected to reach $8.6 billion by 2030

The leading players in the Gene Panel Market are Illumina, Inc., Thermo Fisher Scientific, Agilent Technologies, Inc., QIAGEN, Integrated DNA Technologies, Inc. and Others

Technological advancements in Next-Generation Sequencing (NGS) and direct to consumer (D2C) gene panels are some of the major Gene Panel Market trends in the industry which will create growth opportunities for the market during the forecast period.

The rising prevalence of cancer, awareness regarding rare diseases, increasing investments and R&D in the field of genetics and importance of prenatal screening in high-risk pregnancies are the driving factors of the market.